Surveillance of antibiotic consumption in hospitals: Tasks of the Public Health Service;Surveillance des Antibiotikaverbrauchs in Krankenhäusern: Aufgaben des öffentlichen Gesundheitsdienstes

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 57, Issue 4, 2014, Pages 399-405

  Schweickert, B ^a   Eckmanns, T ^a   Barwolff S ^b   Wischnewski, N ^c   Meyer, E ^d,e  

^a ROBERT KOCH INSTITUTE   (Germany)

^b Gartenarbeitsschule Tempelhof Schoneberg   (Germany)

^c Gesundheitsamt Charlottenburg Wilmersdorf   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e Institute of Pathology   (Germany)

Author keywords

Antibiotic consumption; Public health authorities; Surveillance; 23 IfSG

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; DRUG UTILIZATION; GERMANY; HEALTH SURVEY; LAW; LEGISLATION AND JURISPRUDENCE; PROCEDURES; PUBLIC HEALTH SERVICE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; GERMANY; LEGISLATION, HOSPITAL; POPULATION SURVEILLANCE; PUBLIC HEALTH ADMINISTRATION;

EID: 84897385573     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-014-1942-3     Document Type: Article

References (37)

1. Schweickert B, Kern WV, With K de, et al. (2013) Antibiotika-Verbrauchs- Surveillance. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 56:903-912
2. Robert Koch-Institut (2013) Festlegung der Daten zu Art und Umfang des Antibiotika-Verbrauchs in Krankenhäusern nach § 23 Abs. 4 Satz 2 IfSG. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 56:996-1002
3. European Commission (2011) Actionplan against the rising threats from antimicrobial resistance. http://ec.europa.eu/dgs/health-consumer/docs/ communication-amr-2011-748-en.pdf
4. Goossens H (2009) Antibiotic consumption and link to resistance. Clin Microbiol Infect 15(Suppl 3):12-15
5. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E (2006) Emergence and resurgence of Methicillin resistant Staphylococcus aureus as a public-health threat. Lancet 368:874-885
6. Adam HJ, Hoban DJ, Gin AS, Zhanel GG (2009) Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006. Int J Antimicrob Agents 34:82-85
7. Pakyz AL, Oinonen M, Polk RE (2009) Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 53:1983-1986
8. Polk RE, Johnson CK, McClish D, et al. (2004) Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities. Clin Infect Dis 39:497-503
9. Baquero F, Baquero-Artigao G, Cantón R, García-Rey C (2002) Antibiotic consumption and resistance selection in Streptococcus pneumoniae. J Antimicrob Chemother 50(S2):27-37
10. Cizman M (2003) The use and resistance to antibiotics in the community. Int J Antimicrob Agents 21:297-307
11. García-Rey C, Martín-Herrero JE, Baquero F (2006) Antibiotic consumption and generation of resistance in Streptococcus pneumoniae: the paradoxical impact of quinolones in a complex selective landscape. Clin Microbiol Infect 12:55-66
12. Chen J, Liu L, Wang G, et al. (2009) Correlation between usage of macrolide antibiotic and resistance of Streptococcus pneumoniae clinic isolates from Chongqing children's hospital. Pediatr Pulmonol 44:917-921
13. Kern WV, With K de (2012) Rationale Antibiotikaverordnung. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 55:1418-1426
14. Souli M, Galani I, Giamarellou H (2008) Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 13(47)
15. Coque TM, Baquero F, Canton R (2008) Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 13(47)
16. Meyer E, Gastmeier P, Schwab F (2008) The burden of multiresistant bacteria in German intensive care units. J Antimicrob Chemother 62:1474-1476
17. Maragakis LL, Perencevich EN, Cosgrove SE (2008) Clinical and economic burden of antimicrobial resistance. Expert Rev Anti Infect Ther 6:751-763
18. Freire-Moran L, Aronsson B, Manz C, et al. (2011) Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now. Drug Resist Updat 14:118-124
19. ECDC, EMEA (2009) Technical report: the bacterial challenge: time to react, a call to narrow the gap between multi-resistant bacteria in the EU and the development of new antibacterial agents. http://ecdc.europa.eu/en/ publications/Publications/0909-TER-The-Bacterial-Challenge-Time-to-React.pdf
20. Commission of the European Communities (2001) Communication from the commission on a community strategy against antimicrobial resistance. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2001:0333:FIN:EN:PDF
21. Society for Healthcare Epidemiology of America, Infectious Diseases Society of America, Pediatric Infectious Diseases Society (2012) Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol 33:322-327
22. Commision of the European Communities (2001) Council Recommendation on the prudent use of antimicrobial agents in human medicine. http://eur-lex. europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2002:034:0013:0016:en:pdf
23. European Center for Disease and Infection Control (ECDC), European Surveillance of Antibiotic Consumption Network (ESAC-NET). http://ecdc.europa. eu/en/activities/surveillance/ESAC-Net/Pages/index.aspx
24. Bundesministerium für Gesundheit, Deutschland (2008) Deutsche Antibiotika-Resistenz Strategie (DART). http://www.bundesgesundheitsministerium. de/fileadmin/dateien/Publikationen/Gesundheit/Broschueren/Deutsche-Antibiotika- Resistenzstrategie-DART-110331.pdf
25. Deutsche Gesellschaft für Infektiologie. http://www.dgi-net.de/
26. Antibiotic stewardship. http://www.antibiotic-stewardship.de/cms/index. php?id=3
27. Allerberger F, Lechner A, Wechsler-Fördös A, Gareis R (2008) Optimization of antibiotic use in hospitals-antimicrobial stewardship and the EU project ABS international. Chemotherapy 54:260-267
28. Dellit TH, Owens RC, McGowan JE Jr, et al. (2007) Guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44:159-177
29. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2013) Strategien zur Sicherung rationaler Antibiotika-Anwendung im Krankenhaus. http://www.awmf.org/uploads/tx- szleitlinien/092-001l-S3-Antibiotika-Anwendung-im-Krankenhaus-2013-12.pdf
30. Deutsche Gesellschaft für Krankenhaushygiene. http://www. krankenhaushygiene.de/veranstaltungen/abs/
31. Niedersächsisches Landesgesundheitsamt. http://www.fortbildung.nlga. niedersachsen.de/
32. ADKA-IF-RKI - Projekt. http://www.antiinfektiva-surveillance.de/
33. Surveillance der Antibiotika-Anwendung und der bakteriellen Infektionen auf Intensivstationen, SARI. http://sari.eu-burden.info
34. Ibrahim OM, Polk R (2012) Benchmarking antimicrobial drug use in hospitals. Expert Rev Anti Infect Ther 10:445-457
35. Thern J, de With K, Strauss R, Steib-Bauert M, Weber N, Kern WV (2013) Selection of hospital antimicrobial prescribing quality indicators: a consensus among German antibiotic stewardship (ABS) networkers. Infection [Epub ahead of print]
36. Zarb P, Amadeo B, Muller A, et al. (2011) Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009. J Antimicrob Chemother 66:443-449
37. Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P (2010) Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit Care 3:R113